NCT06603571: A Study to Investigate Weight Management With LY3841136 and Tirzepatide (LY3298176), Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- State
- Completed
- Phase
- Phase 2
- People
- 367 taking part
- Started
- 20 Sep 2024
- Primary completion
- 1 Jul 2026
- Arms
- LY3841136 Dose 1, LY3841136 Dose 2, LY3841136 Dose 3, LY3841136 Dose 1 + Tirzepatide Dose 1, LY3841136 Dose 2 + Tirzepatide Dose 1, LY3841136 Dose 2 + Tirzepatide Dose 2, LY3841136 Dose 3 + Tirzepatide Dose 3, LY3841136 Dose 2 + Tirzepatide Dose 3
- Results
- None posted
- 19 Sep 2024: Trial registered
- 20 Sep 2024: Trial started
- 14 Sep 2026: Trial completed